| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0945-053X(00)00102-5 |
| P698 | PubMed publication ID | 11102751 |
| P2093 | author name string | Ye S | |
| P2860 | cites work | Apolipoprotein E and Alzheimer disease | Q24563061 |
| Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis | Q24563251 | ||
| Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms | Q28137791 | ||
| Matrix metalloproteinases | Q28140451 | ||
| Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis | Q28140599 | ||
| Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction | Q28144912 | ||
| Human stromelysin gene promoter activity is modulated by transcription factor ZBP-89 | Q28198820 | ||
| Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm | Q28245985 | ||
| Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression | Q28281614 | ||
| Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor | Q28288345 | ||
| Metalloproteinases and their inhibitors in matrix remodeling | Q28305537 | ||
| Matrix metalloproteinases: a review | Q29620220 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis | Q33783677 | ||
| Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
| Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene | Q34384764 | ||
| Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3). | Q35075746 | ||
| Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter | Q36617312 | ||
| Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization | Q37594710 | ||
| Acute coronary thrombosis--the role of plaque disruption and its initiation and prevention | Q41162503 | ||
| Impaired wound contraction in stromelysin-1-deficient mice | Q41685687 | ||
| Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes | Q47671940 | ||
| Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease | Q47700813 | ||
| A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. | Q48041239 | ||
| Characterization of a dinucleotide repeat in the 92 kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease | Q48076276 | ||
| Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis | Q48105784 | ||
| Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma. | Q52973689 | ||
| Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer. | Q53000471 | ||
| A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. | Q53221276 | ||
| Epidermal expression of collagenase delays wound-healing in transgenic mice. | Q53940693 | ||
| Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. | Q54569934 | ||
| A DNA Polymorphism Discovery Resource for Research on Human Genetic Variation: Table 1 | Q56566320 | ||
| The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study | Q56804140 | ||
| Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1 | Q57279239 | ||
| Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis | Q57279243 | ||
| Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis | Q57584581 | ||
| Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease | Q57607780 | ||
| Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases | Q71971790 | ||
| Plasma concentration of matrix metalloproteinase 9 in gastric cancer | Q73095913 | ||
| Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm | Q73230342 | ||
| Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery | Q73254515 | ||
| Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease | Q73378459 | ||
| Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects | Q73876920 | ||
| Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms | Q77773046 | ||
| Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis | Q77989674 | ||
| Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene | Q78068271 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 623-629 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Matrix Biology | Q6787851 |
| P1476 | title | Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases | |
| P478 | volume | 19 |
| Q36277983 | "Coelionomics": towards understanding the molecular pathology of coeliac disease |
| Q53353609 | A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer. |
| Q36689684 | Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs |
| Q28082608 | Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9 |
| Q46905839 | Analysis of MMP-9 and TIMP-2 gene promoter polymorphisms in individuals with hypodontia |
| Q38104242 | Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis |
| Q35205043 | Association between the MMP-9-1562 C>T polymorphism and the risk of stroke: a meta-analysis |
| Q47866665 | Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). |
| Q57825618 | Association of Gene Polymorphism with Predisposition to Optic Neuritis and Optic Neuritis Together with Multiple Sclerosis |
| Q36087151 | Association of MMP3 and TIMP2 promoter polymorphisms with nonsyndromic oral clefts. |
| Q64104030 | Association of Matrix Metalloproteinase 9 () Polymorphisms with Asthma Risk: A Meta-Analysis |
| Q58558389 | Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer |
| Q24800622 | Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis |
| Q37143059 | Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the Chinese Han population: a case-control study |
| Q49843962 | Association of matrix metalloprotease 1, 3, and 12 polymorphisms with rheumatic heart disease in a Chinese Han population. |
| Q38184472 | Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysis |
| Q84588752 | Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India |
| Q53528851 | Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children. |
| Q28394861 | Associations of MMP1, MMP2 and MMP3 Genes Polymorphism with Coal Workers' Pneumoconiosis in Chinese Han Population |
| Q35111979 | Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects |
| Q28248012 | BAK1 gene variation and abdominal aortic aneurysms |
| Q36938166 | Biological and functional analysis of statistically significant pathways deregulated in colon cancer by using gene expression profiles |
| Q49683575 | Capicua suppresses hepatocellular carcinoma progression by controlling ETV4-MMP1 axis |
| Q62399624 | Chronopotentiometric Stripping Analysis of Gelatinase B, Collagen and Their Interaction |
| Q53646618 | Collagen binding alpha2beta1 and alpha1beta1 integrins play contrasting roles in regulation of Ets-1 expression in human liver myofibroblasts. |
| Q36430744 | Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model |
| Q93051804 | Contribution of Matrix Metalloproteinase-2 Promoter Genotypes to Nasopharyngeal Cancer Susceptibility and Metastasis in Taiwan |
| Q74694126 | Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study |
| Q36492726 | Correlations of MMP-2 and TIMP-2 gene polymorphisms with the risk and prognosis of gastric cancer |
| Q37670089 | Does matrix metalloproteinase-3 polymorphism play a role in age-related macular degeneration in patients with myocardial infarction? |
| Q38377170 | Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis |
| Q24792943 | Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study |
| Q33650172 | Engineering complex tissues |
| Q33552910 | Evaluation of MMP1 and MMP3 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma |
| Q73583580 | Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients |
| Q37088998 | Evaluation of physiological risk factors, oxidant-antioxidant imbalance, proteolytic and genetic variations of matrix metalloproteinase-9 in patients with pressure ulcer |
| Q39467997 | Extracellular 14-3-3 from human lung epithelial cells enhances MMP-1 expression |
| Q42755979 | Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome |
| Q44602463 | Fra‐1 targets the AP‐1 site/2G single nucleotide polymorphism (ETS site) in the MMP‐1 promoter |
| Q40736375 | Frequency of the common promoter polymorphism MMP2 -1306 C>T in a population from central Bulgaria |
| Q80559739 | Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma |
| Q42843297 | Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk |
| Q84193058 | Gastric carcinogenesis |
| Q37784295 | Gene Polymorphisms in Renal Transplantation |
| Q24810657 | Genetic polymorphisms in the matrix metalloproteinase 12 gene (MMP12) and breast cancer risk and survival: the Shanghai Breast Cancer Study |
| Q33264591 | Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma |
| Q33758871 | Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. |
| Q37886401 | Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review |
| Q42221992 | Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor. |
| Q29620360 | How matrix metalloproteinases regulate cell behavior |
| Q40898983 | Human Polymorphisms in Placentally Expressed Genes and Their Association With Susceptibility to Congenital Trypanosoma cruzi Infection |
| Q34330943 | Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase |
| Q38289365 | Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter |
| Q38295827 | Identification of genetic alterations in the TGFbeta type II receptor gene promoter. |
| Q44810471 | Identifying the regulative role of NF-κB binding sites within promoter region of human matrix metalloproteinase 9 (mmp-9) by TNF-α induction |
| Q36946216 | Impact of CCL2 and Its Receptor CCR2 Gene Polymorphism in North Indian Population: A Comparative Study in Different Ethnic Groups Worldwide |
| Q46636318 | Influence of matrix metalloproteinase-1 gene -1607 (1G/2G) (rs1799750) promoter polymorphism on circulating levels of MMP-1 in chronic pancreatitis |
| Q37815128 | Jekyll and Hyde: the role of the microenvironment on the progression of cancer |
| Q37528852 | MMP-1 polymorphism and its relationship to pathological processes. |
| Q35924083 | MMP-2 gene polymorphisms in type 2 diabetes mellitus diabetic retinopathy |
| Q46755360 | MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population |
| Q33820443 | MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study |
| Q36908023 | MMPs as therapeutic targets--still a viable option? |
| Q51626814 | Matrix Matalloproteinase-8 Gene Polymorphism in Chronic Periapical Lesions. |
| Q38414016 | Matrix Metalloproteinase Gene Polymorphisms and New-Onset Diabetes After Kidney Transplantation in Korean Renal Transplant Subjects |
| Q35795815 | Matrix Metalloproteinase-3 -1171 5A/6A Polymorphism (rs35068180) is Associated with Risk of Periodontitis |
| Q92286667 | Matrix Metalloproteinases (MMP-2,-3,-9) Gene Polymorphisms in Cases of Benign Vocal Fold Lesions and Laryngeal Carcinoma |
| Q36761849 | Matrix metalloproteases: underutilized targets for drug delivery |
| Q45333558 | Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene polymorphisms in generalized aggressive periodontitis: gingival crevicular fluid MMP-8 and TIMP-1 levels and outcome of periodontal therapy |
| Q84423123 | Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: a meta-analysis |
| Q38181105 | Matrix metalloproteinase gene polymorphisms and oral cancer. |
| Q84018234 | Matrix metalloproteinase gene polymorphisms in patients with rheumatoid arthritis |
| Q37869122 | Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma |
| Q51571077 | Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages. |
| Q38068476 | Matrix metalloproteinase-2 as a target for head and neck cancer therapy |
| Q54444143 | Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility. |
| Q38234888 | Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines. |
| Q28262443 | Matrix metalloproteinase-9 polymorphism 1562 C > T (rs3918242) associated with protection against placental malaria |
| Q36179963 | Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer |
| Q35692009 | Matrix metalloproteinases and atherosclerosis |
| Q37195730 | Matrix metalloproteinases and cardiovascular diseases. |
| Q37000242 | Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications |
| Q33337157 | Matrix metalloproteinases: a tail of a frog that became a prince |
| Q36580334 | Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. |
| Q36752100 | Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability |
| Q34700849 | Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk |
| Q37871441 | Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer |
| Q38991475 | Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients |
| Q28204201 | Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome |
| Q58408445 | Métalloprotéases de la matrice extracellulaire et cancers du tractus digestif |
| Q30874840 | N-Glycosylation pattern of the zymogenic form of human matrix metalloproteinase-9. |
| Q35171753 | Oral infections and systemic diseases |
| Q34009450 | Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension |
| Q37433714 | Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease |
| Q80742135 | Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis |
| Q39937065 | Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies. |
| Q54632095 | Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. |
| Q38411740 | Polymorphisms of MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis. A meta-analysis |
| Q52859829 | Premature coronary artery disease shows no evidence of linkage to loci encoding for tissue inhibitors of matrix metalloproteinases. |
| Q33608536 | Progress in matrix metalloproteinase research |
| Q24534066 | Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin |
| Q35536812 | Promoter variants in tissue inhibitor of metalloproteinase-3 (TIMP-3) protect against susceptibility in pigeon breeders' disease |
| Q37097775 | Proteomic analysis of the supernatant of red blood cell units: the effects of storage and leucoreduction |
| Q35911136 | Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases |
| Q35636526 | Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. |
| Q36718903 | Role of MMP-2 (-1306 C/T) Polymorphism in Pituitary Adenoma |
| Q54345992 | Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population. |
| Q34981278 | Role of genetic polymorphisms in tumour angiogenesis |
| Q45346852 | Single nucleotide polymorphisms of matrix metallopeptidase 3 and risk of gliomas in a Chinese Han population |
| Q33952599 | Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer |
| Q33301753 | The 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma |
| Q55465839 | The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Breast Cancer. |
| Q41487339 | The Contribution of MMP-7 Promoter Polymorphisms in Renal Cell Carcinoma |
| Q41487291 | The Contribution of Matrix Metalloproteinase-8 Promoter Polymorphism to Oral Cancer Susceptibility |
| Q34334236 | The GC + CC genotype at position -418 in TIMP-2 promoter and the -1575GA/-1306CC genotype in MMP-2 is genetic predisposing factors for prevalence of moyamoya disease |
| Q47116540 | The Profile of MMP-9, MMP-9 mRNA Expression, -1562 C/T Polymorphism and Outcome in High-risk Traumatic Brain Injury: The Effect of Therapeutic Mild Hypothermia |
| Q51562377 | The association between MMP2 -1306 C > T (rs243865) polymorphism and risk of prostate cancer. |
| Q47156148 | The association of matrix metalloproteinase-9 promoter polymorphisms with gastric cancer risk: a meta-analysis |
| Q36610051 | The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer |
| Q36012883 | The genetic basis for altered blood vessel function in disease: large artery stiffening |
| Q40912702 | The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection |
| Q36758426 | The role of matrix metalloproteinases in the oral environment |
| Q39191612 | Towards integrating extracellular matrix and immunological pathways. |
Search more.